A synergistically enhanced T(1) -T(2) dual-modal contrast agent.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 22972529.
- Also identified by DOI 10.1002/adma.201203169 and PMC identifier 3634350.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Monodisperse Gd(2) O(3) -embedded iron oxide (GdIO) nanoparticles can simultaneously enhance the local magnetic field intensities of each other under an external magnetic field and result in synergistic enhancement of T(1) and T(2) effects. GdIO nanoparticles have the unique property to be both T(1) and T(2) contrast agents and can potentially lead to higher accuracy in cancer diagnosis, particularly liver tumors.
Medical subject headings
- Contrast Media